JP2013515049A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515049A5 JP2013515049A5 JP2012545493A JP2012545493A JP2013515049A5 JP 2013515049 A5 JP2013515049 A5 JP 2013515049A5 JP 2012545493 A JP2012545493 A JP 2012545493A JP 2012545493 A JP2012545493 A JP 2012545493A JP 2013515049 A5 JP2013515049 A5 JP 2013515049A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- klh
- concentration
- present
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28908309P | 2009-12-22 | 2009-12-22 | |
| US61/289,083 | 2009-12-22 | ||
| PCT/IB2010/055674 WO2011077309A2 (en) | 2009-12-22 | 2010-12-08 | Vaccine compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015105966A Division JP6146927B2 (ja) | 2009-12-22 | 2015-05-26 | ワクチン組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515049A JP2013515049A (ja) | 2013-05-02 |
| JP2013515049A5 true JP2013515049A5 (enExample) | 2014-01-30 |
| JP6007105B2 JP6007105B2 (ja) | 2016-10-12 |
Family
ID=43797591
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012545493A Expired - Fee Related JP6007105B2 (ja) | 2009-12-22 | 2010-12-08 | ワクチン組成物 |
| JP2015105966A Expired - Fee Related JP6146927B2 (ja) | 2009-12-22 | 2015-05-26 | ワクチン組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015105966A Expired - Fee Related JP6146927B2 (ja) | 2009-12-22 | 2015-05-26 | ワクチン組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20130034573A1 (enExample) |
| EP (2) | EP2515934B1 (enExample) |
| JP (2) | JP6007105B2 (enExample) |
| KR (1) | KR20120120185A (enExample) |
| CN (2) | CN102762224A (enExample) |
| AU (1) | AU2010334428B2 (enExample) |
| CA (1) | CA2785585A1 (enExample) |
| IL (1) | IL220308A0 (enExample) |
| MX (1) | MX337070B (enExample) |
| NZ (2) | NZ629256A (enExample) |
| RU (1) | RU2581020C2 (enExample) |
| SG (2) | SG181628A1 (enExample) |
| WO (1) | WO2011077309A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2769629T3 (es) * | 2010-02-21 | 2020-06-26 | Bayer Healthcare Llc | Procedimiento de activación y conjugación de biomoléculas |
| KR101502360B1 (ko) * | 2013-03-20 | 2015-03-25 | 주식회사 옵티팜 | 신규한 국내형 돼지생식기호흡기증후군 바이러스 |
| US20200087390A1 (en) | 2016-12-21 | 2020-03-19 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| AU2019305221B2 (en) * | 2018-07-19 | 2024-11-07 | Helixmith Co., Ltd. | Lyophilized pharmaceutical compositions for naked DNA gene therapy |
| US20220273755A1 (en) * | 2019-11-21 | 2022-09-01 | Multiple Fortune Holding Limited | Pharmaceutical composition, use and method for applying ganoderma microsporum immunomodulatory protein and keyhole limpet hemocyanin in carcinoma treatment |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH600453A5 (enExample) | 1976-12-30 | 1978-06-15 | Autelca Ag | |
| GB8815795D0 (en) | 1988-07-02 | 1988-08-10 | Bkl Extrusions Ltd | Glazing bead |
| NZ230747A (en) | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| CA2066428C (en) | 1989-09-08 | 2000-11-28 | Bert Vogelstein | Structural alterations of the egf receptor gene in human gliomas |
| CA2138997C (en) | 1992-06-25 | 2003-06-03 | Jean-Paul Prieels | Vaccine composition containing adjuvants |
| SG48309A1 (en) | 1993-03-23 | 1998-04-17 | Smithkline Beecham Biolog | Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| FR2719479B1 (fr) * | 1994-05-04 | 1996-07-26 | Sanofi Elf | Formulation stable lyophilisée comprenant une protéine: kit de dosage. |
| WO1996002555A1 (en) | 1994-07-15 | 1996-02-01 | The University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| WO1996016988A1 (en) * | 1994-11-28 | 1996-06-06 | Thomas Jefferson University | Reagents and processes for targeting mutant epidermal growth factor receptors |
| GB9513261D0 (en) | 1995-06-29 | 1995-09-06 | Smithkline Beecham Biolog | Vaccines |
| JP4111403B2 (ja) | 1996-10-11 | 2008-07-02 | ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア | 免疫刺激ポリヌクレオチド／免疫調節分子複合体 |
| AUPO517897A0 (en) | 1997-02-19 | 1997-04-11 | Csl Limited | Chelating immunostimulating complexes |
| WO1998037919A1 (en) | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
| AU753688B2 (en) | 1997-03-10 | 2002-10-24 | Ottawa Civic Loeb Research Institute | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| AU7690898A (en) | 1997-05-20 | 1998-12-11 | Ottawa Civic Hospital Loeb Research Institute | Vectors and methods for immunization or therapeutic protocols |
| WO1998055495A2 (en) | 1997-06-06 | 1998-12-10 | Dynavax Technologies Corporation | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| GB9712347D0 (en) | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
| US5972623A (en) * | 1997-07-31 | 1999-10-26 | Metra Biosystems, Inc. | Collagen-peptide assay method |
| DK1007546T3 (da) * | 1997-08-27 | 2009-03-16 | Novartis Vaccines & Diagnostic | Molekylære mimetika af meningokok-B-epitoper |
| AU1145699A (en) | 1997-09-05 | 1999-03-22 | Smithkline Beecham Biologicals (Sa) | Oil in water emulsions containing saponins |
| US6303114B1 (en) | 1998-03-05 | 2001-10-16 | The Medical College Of Ohio | IL-12 enhancement of immune responses to T-independent antigens |
| WO1999052549A1 (en) | 1998-04-09 | 1999-10-21 | Smithkline Beecham Biologicals S.A. | Adjuvant compositions |
| GB9817052D0 (en) | 1998-08-05 | 1998-09-30 | Smithkline Beecham Biolog | Vaccine |
| TW570805B (en) * | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
| AU750587B2 (en) | 1998-10-16 | 2002-07-25 | Smithkline Beecham Biologicals (Sa) | Adjuvant systems and vaccines |
| AUPP807399A0 (en) | 1999-01-08 | 1999-02-04 | Csl Limited | Improved immunogenic lhrh composition and methods relating thereto |
| ES2572834T3 (es) | 1999-02-17 | 2016-06-02 | Csl Limited | Complejos inmunogénicos y métodos relacionados con los mismos |
| JP2002539273A (ja) | 1999-03-19 | 2002-11-19 | スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム | ワクチン |
| JP2001163801A (ja) * | 1999-04-02 | 2001-06-19 | Oriental Yeast Co Ltd | 乾燥ｃ反応性タンパク質組成物 |
| CN1227030C (zh) | 1999-04-19 | 2005-11-16 | 史密丝克莱恩比彻姆生物有限公司 | 包含皂甙和免疫刺激寡核苷酸的佐剂组合物 |
| JP2003509473A (ja) | 1999-09-24 | 2003-03-11 | スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム | ワクチン |
| CO5200838A1 (es) | 1999-09-24 | 2002-09-27 | Smithkline Beecham Corp | Vacunas |
| US6911204B2 (en) * | 2000-08-11 | 2005-06-28 | Favrille, Inc. | Method and composition for altering a B cell mediated pathology |
| EP3192528A1 (en) * | 2002-02-14 | 2017-07-19 | Chugai Seiyaku Kabushiki Kaisha | Formulation of anti-il6r antibody-containing solutions comprising a sugar as a stabilizer |
| ES2352668T3 (es) * | 2002-08-14 | 2011-02-22 | Mitsubishi Chemical Medience Corporation | Anticuerpo específico para una proteína tau del sistema nervioso central. |
| JP4504098B2 (ja) * | 2003-05-28 | 2010-07-14 | 武田薬品工業株式会社 | 抗体およびその用途 |
| US7736644B2 (en) * | 2003-06-27 | 2010-06-15 | Amgen Fremont Inc. | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| JP2007511539A (ja) * | 2003-11-14 | 2007-05-10 | バクスター・インターナショナル・インコーポレイテッド | α１−抗トリプシン組成物およびこのような組成物を用いた処置方法 |
| CA2572427A1 (en) | 2004-07-18 | 2006-01-18 | Heather L. Davis | Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses |
| AU2005333126A1 (en) | 2004-07-18 | 2006-12-21 | Csl Limited | Methods and compositions for inducing innate immune responses |
| BRPI0609932A2 (pt) * | 2005-05-24 | 2011-10-11 | Neovacs | métodos para preparar um produto imunogênico anti-tnfalfa e para preparar uma composição de vacina, produto imunogênico anti-tnfalfa, composição imunogênica, e, composição de vacina |
| CN104857500A (zh) * | 2005-11-02 | 2015-08-26 | 杜克大学 | 同时的化学疗法和免疫疗法 |
| MX2010001684A (es) * | 2007-08-15 | 2010-04-21 | Amunix Inc | Composiciones y metodos para modificar propiedades de polipeptidos biologicamente activos. |
| WO2009086400A2 (en) * | 2007-12-28 | 2009-07-09 | Baxter International Inc. | Recombinant vwf formulations |
-
2010
- 2010-12-08 SG SG2012042784A patent/SG181628A1/en unknown
- 2010-12-08 AU AU2010334428A patent/AU2010334428B2/en not_active Ceased
- 2010-12-08 NZ NZ629256A patent/NZ629256A/en not_active IP Right Cessation
- 2010-12-08 EP EP10807742.1A patent/EP2515934B1/en not_active Not-in-force
- 2010-12-08 SG SG10201408505SA patent/SG10201408505SA/en unknown
- 2010-12-08 JP JP2012545493A patent/JP6007105B2/ja not_active Expired - Fee Related
- 2010-12-08 CN CN2010800584328A patent/CN102762224A/zh active Pending
- 2010-12-08 KR KR1020127016787A patent/KR20120120185A/ko not_active Ceased
- 2010-12-08 CA CA2785585A patent/CA2785585A1/en not_active Abandoned
- 2010-12-08 US US13/517,394 patent/US20130034573A1/en not_active Abandoned
- 2010-12-08 EP EP17170910.8A patent/EP3257525A3/en not_active Withdrawn
- 2010-12-08 NZ NZ600978A patent/NZ600978A/en not_active IP Right Cessation
- 2010-12-08 RU RU2012131162/15A patent/RU2581020C2/ru not_active IP Right Cessation
- 2010-12-08 CN CN201611022843.7A patent/CN107412754A/zh active Pending
- 2010-12-08 MX MX2012007283A patent/MX337070B/es active IP Right Grant
- 2010-12-08 WO PCT/IB2010/055674 patent/WO2011077309A2/en not_active Ceased
-
2012
- 2012-06-11 IL IL220308A patent/IL220308A0/en unknown
-
2014
- 2014-12-04 US US14/560,462 patent/US20150087815A1/en not_active Abandoned
-
2015
- 2015-05-26 JP JP2015105966A patent/JP6146927B2/ja not_active Expired - Fee Related
-
2019
- 2019-01-10 US US16/244,358 patent/US20190365886A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013531679A5 (enExample) | ||
| CN111971062A (zh) | 一种抗人pd-1的单克隆抗体制剂、联合用药物及其用途 | |
| JP2021512881A5 (enExample) | ||
| JP2016534052A5 (enExample) | ||
| JP2021046436A (ja) | ペプチド模倣大環状分子およびその製剤 | |
| RU2011127913A (ru) | Составы, содержащие антитела | |
| KR20200097295A (ko) | 분지형 링커를 갖는 튜불리신 유사체의 접합체 | |
| JP2011173914A5 (enExample) | ||
| JP2021504372A5 (enExample) | ||
| US11759497B2 (en) | Daptomycin formulations | |
| KR20210122318A (ko) | 비스-링키지를 사용한 세포독성 약물의 접합 | |
| IL294463A (en) | Methods for treating or preventing eye conditions | |
| KR20020026558A (ko) | 키메라성 폴리펩타이드, 이의 제조 방법 및 용도 | |
| JP2017514868A5 (enExample) | ||
| RS54083B1 (sr) | Derivati metastina i njihova upotreba | |
| RU2013128361A (ru) | Her2-связывающие белки, меченые комплексом 18f-фторида алюминия и nota | |
| JP2024508762A5 (enExample) | ||
| RU2020109881A (ru) | Агонисты рецепторов glp-1/глюкагона в лечении жировой болезни печени и стеатогепатита | |
| CN111148510A (zh) | 用于治疗性蛋白质的冻干药物配制品的方法 | |
| JP2007534698A5 (enExample) | ||
| JP7126270B2 (ja) | Ｎｐｒａアゴニスト、組成物およびその使用 | |
| JP6580581B2 (ja) | 注射用医薬組成物 | |
| RU2018129077A (ru) | Стабильная фармацевтическая композиция | |
| JP2021519790A5 (enExample) | ||
| JP2024515676A (ja) | ポリペプチド製剤 |